Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Moxian, Inc. (MOXC) Makes NASDAQ Move Up Motions

Moxian, Inc. (OTCQB: MOXC) is gearing up for a NASDAQ listing. In an interview (http://nnw.fm/8DzdP) with Asia Fund Space, Mr. James Tan, CEO of Moxian, spoke passionately about the impending upgrade, likening his company to Facebook (NASDAQ: FB), which in its early years had promising earnings potential but minimal revenues. Tan believes a NASDAQ listing […]

Laguna Blends, Inc.’s (CSE: LAG) (LB6A.F) (OTC: LAGBF) Move to Secure CannaCeuticals Brand Spells Big Things for Network Marketing Pioneer

While the full scope of the health benefits cannabidiol (CBD) and hemp oil have on various human tissues is still not properly understood, a growing body of scientific data has been amassed showing the positive impact on human health from cannabis-derived phtyonutrients, and cannabinoids in particular, from studies directly documenting anti-inflammatory and sebostatic effects (http://nnw.fm/M86rC) […]

Momentous Entertainment Group, Inc. (MMEG) Announces Content Distribution Agreement with Poolworks Germany LTD

Before the opening bell, Momentous Entertainment Group, Inc. (OTC: MMEG) announced entry into a binding agreement with Poolworks Germany LTD, one of the largest social media firms in Germany, through which Momentous will provide Hollywood quality film and television content to an audience of more than 10 million subscribers. According to the terms of this […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.